Skip to content

IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Specimens

IntelliWell: An AI-Assisted Microwell Platform for Label-Free Localization of Ultra-Rare Sperm in Non-Obstructive Azoospermia Micro-TESE Specimens

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07074015
Enrollment
20
Registered
2025-07-20
Start date
2026-04-16
Completion date
2027-12-01
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azoospermia, Infertility

Keywords

infertility, azoospermia, micro-TESE

Brief summary

This study will help determine whether an AI-assisted microwell platform (IntelliWell) can identify rare sperm cells in testicular samples found to not have sperm by conventional analysis. Instead of discarding testicular tissue which was found to be non-sperm bearing by conventional analysis the testicular tissue will be processed using IntelliWell and, if sperm is found and verified by embryologists, it may be used for intracytoplasmic sperm injection (ICSI).

Interventions

DEVICEUse of IntelliWell to identify and localize sperm for ICSI

The experimental arm will have surgically extracted testicular sperm processed with IntelliWell. If identified and confirmed by embryology, cryopreservation of sperm will occur. On day of ICSI, thaw of testicular sperm will occur and be processed by IntelliWell for identification and localization for use in ICSI.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male subjects presenting to Brigham and Women's or Faulkner urology clinic with infertility with clinical non-obstructive azoospermia (clinical diagnosis based on two semen analyses, physical examination, and hormonal testing). 2. Male subjects undergoing micro-surgical testicular sperm extraction surgery at Brigham and Women's Hospital. 3. Surgically extracted sperm which are not found to have clinically usable quantities of sperm after standard of care manual processing for which samples would otherwise be discarded and the procedure deemed unsuccessful.

Exclusion criteria

1\. Female subject (with whom male subjects intends to conceive with surgically extracted sperm) cannot or will not provide her informed consent for study participation. She will undergo ICSI at BWH with BWH embryology.

Design outcomes

Primary

MeasureTime frameDescription
Sperm detection rate by IntelliWell (sperm/min)Date of surgery and date of ICSI
Sperm retrieval success rateDate of surgery and date of ICSIDefined as at least one ICSI-grade sperm retrieved from IntelliWell

Secondary

MeasureTime frame
Total number of sperm detected in IntelliWell in fresh sampleDate of surgery
Total number of sperm detected by IntelliWell in test-thaw samplesDay of surgery
Total number of sperm detected by IntelliWell on day of ICSIDate of ICSI
Time to first sperm detection and time to 10 spermDate of surgery and date of ICSI
Number of IntelliWell-identified sperm verified by embryologyDate of surgery and date of ICSI
Number of sperm retrieved and approved for ICSIDate of ICSI
Total IntelliWell search timeDate of surgery and date of ICSI

Countries

United States

Contacts

CONTACTMartin Kathrins, MD
mkathrins@bwh.harvard.edu617-732-6227
CONTACTSiline Thai
sthai1@bwh.harvard.edu617-525-8793

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026